Biomedical nanocomposites of hydroxyapatite/polycaprolactone obtained by surfactant mediation.
The composite approach to combining bioactive ceramic and degradable polymer is a promising strategy in the development of bone regenerative matrices. Moreover, in the fabrication of composites, the nanoscale organization of each component should improve the level of structural integration as well as the resultant mechanical and biological properties. The aim of this study was to develop a novel nanocomposite system consisting of hydroxyapatite (HA) and poly(epsilon-caprolactone) (PCL), wherein the HA nanoparticles were uniformly dispersed within the PCL matrix. The strategy was based on applying an amphiphilic surfactant, oleic acid in this case, between the HA and PCL. Oleic acid, which belongs to the fatty acid family and is generally noncytotoxic at the levels used in this study, is believed to mediate the interaction between the hydrophilic HA and hydrophobic PCL. With the mediation of oleic acid, the HA nanoparticles were distributed uniformly within the PCL matrix on the nanoscale (distributed particle size of less than 1 microm), which is in marked contrast to the conventionally mixed HA-PCL composite, in which the HA particles were severely agglomerated. The developed nanocomposite had significantly higher mechanical strength than did the conventional composite and the pure PCL. Moreover, the osteoblastic cells showed a better proliferation behavior on the nanocomposite than on the conventional composite. This HA-PCL nanocomposite mediated by oleic acid is expected to be useful in the bone regeneration field. Moreover, this methodology is applicable to the nanocomposite processing of other biomedical materials.
Kim
Hae-Won
HW
Department of Biomaterials Science, School of Dentistry, Dankook University, Cheonan 330 714, Korea. kimhw@dankook.ac.kr
D001672:Biocompatible Materials / Q000138:chemical synthesis*; D002208:Caproates / Q000737:chemistry*; D002460:Cell Line; D049109:Cell Proliferation / Q000187:drug effects; D017886:Durapatite / Q000737:chemistry*; D006801:Humans; D007783:Lactones / Q000737:chemistry*; D008855:Microscopy, Electron, Scanning; D046529:Microscopy, Electron, Transmission; D053761:Nanocomposites; D019301:Oleic Acid / Q000494:pharmacology; D010006:Osteoblasts / Q000166:cytology / Q000187:drug effects; D012996:Solutions; D013314:Stress, Mechanical; D013501:Surface-Active Agents / Q000494:pharmacology*; D013718:Tensile Strength / Q000187:drug effects
D001672:Biocompatible Materials; D002208:Caproates; D007783:Lactones; D012996:Solutions; D013501:Surface-Active Agents; D019301:Oleic Acid; C121056:caprolactone; D017886:Durapatite